Summary: Basement membrane thickening and mesangial expansion characterize the renal involvement in diabetes mellitus and precede any symptoms of renal dysfunction, e. g., albuminuria and changes in glomerular filtration rate. Since the morphological changes can only be diagnosed by biopsy, this study was designed to investigate whether the urinary excretion of renal extracellular matrix proteins might reflect the morphological alterations.
Laminin concentrations in serum and in urine did not change in diabetics. Collagen IV decreased in serum of patients with increased albumin excretion (controls: χ = 255 μg/l, normoalbuminuric patients: χ = 56 μg/l J microalbuminuric patients: χ = 52 μg/l, and patients with overt albuminuria: χ = 70 μg/l; α < 0.01) and increased in urine (controls, normoalbuminuric and microalbuminuric patients: not detectable, patients with overt albuminuria: χ = 5 ng/12 h; α < 0.001). Fibronectin was elevated in serum (controls: χ = 355 mg/1; normoalbuminuric patients: χ = 640 mg/1, microalbuminuric patients: χ = 710 mg/1, and patients with overt albuminuria: χ = 630 mg/1; α < 0.0001) and in urine, even in patients with normal albumin excretion (controls: χ = 16.8 μg/12 h, normoalbuminuric patients: x= 121 μg/12h, microalbuminuric patients: x = 108μg/12h, patients with overt albuminuria: χ = 186 \ig/l2 h; α < 0.01). The urinary fragment pattern of fibronectin, consisting of two main bands of a relative molecular mass of M r 75000 and 45000, was not altered in controls and diabetics. Type I and type II diabetic patients did not show significant differences in any quantities tested.
It was shown in this study that the determination of laminin and collagen IV in serum and urine gave no information exceeding the routinely used quantities of kidney function. But the renal fibronectin excretion was elevated before any functional changes occurred. It was concluded that this might be indicative of the early mesangial expansion in diabetes mellitus. The determination of urinary fibronectin could therefore probably serve as a more sensitive marker for renal involvement in diabetes mellitus than microalbuminuria or changes in glomerular filtration rate.
Introduction
About 45% of type I diabetic patients develop overt diabetic nephropathy in the course of their disease. One quarter of all new cases of uraemia are due to this diabetic complication (1) . These facts underscore the necessity of carefully monitoring kidney function in diabetic patients. Microalburninuria is currently the first sign that may indicate an incipient diabetic nephropathy. Approximately 80% of younger diabetic patients and 20% of elder patients with microalbuminuria progress to overt 'diabetic nephropathy (2) . However, before microalbuminuria can be diagnosed, morphological alterations in the kidney, such as basement membrane thickening and mesangial expansion, occur (3) . Maurer et al. (4) demonstrated that mesangial expansion especially correlates with the clinical manifestation of diabetic nephropathy.
The morphological alterations are due to changes in the metabolism, composition and integrity of the renal extracellular matrix induced by the metabolic disorders in diabetes (5) . It was demonstrated that in mild to moderate diabetic nephropathy laminin, collagen IV, and fibronectin accumulate in the glomerular extracellular matrix (6) (7) (8) , while the amount of these structural proteins within the glomerular apparatus is drastically reduced in the advanced stage of the disease coinciding with glomerular sclerosis (6, 7) . Further, the decrease of sulphated proteoglycans in the glomerular basement membrane in diabetes leads to the loss of the charge selectivity, and consequently to glomerular proteinuria (9) .
To date, the morphological alterations can only be diagnosed by biopsy and subsequent immunohistochemistry or electronmicroscopy. Since these methods are not indicated in monitoring the state of the kidney in diabetic patients, the question arises whether the changes in the renal extracellular matrix might be reflected by an altered excretion of the relevant proteins in final urine. Little is known about the urinary excretion of structural proteins. Weil et al. (10) described a decreased excretion of "glomerular basement membrane-like protein" in the urine of diabetic rats. Mellon et al. (11) and Torffvit et al. (12) found an increased collagen IV excretion in congenitally diabetic mice and in men with progressing albumin excretion, respectively. Therefore, the aim of the present study was to investigate the relevance of the urinary excretion of extracellular matrix proteins, especially in the early phases of renal involvement in diabetes mellitus. Collagen IV, laminin, and fibronectin as the major intrinsic components of the glomerular basement membrane and the mesangial matrix were determined in the urine of type I and type II diabetic patients without any symptoms of diabetic nephropathy and at different stages of this disease.
Patients and Methods

Subjects
In this trial 86 in-patients of a Diabetes Hospital with type I diabetes (insulin-dependent; n = 34) and type II diabetes (non-insulin dependent, n = 52) were examined. To be included in this study, the patients had to have a known history of diabetic nephropathy or no symptoms of renal involvement in diabetes. Subjects with a renal disease different from diabetic nephropathy, benign or malignant tumours, inflammatory processes, recent surgery, and pregnant women were excluded from this study. The detailed clinical data on the patients are listed in table 1. Type I diabetics received insulin injections. Nineteen type II diabetics were treated with oral sulphonylurea antidiabetics (glibenclamide, Euglucon®; glipizide, Glibenese®), 18 with insulin, 10 with a combination of both, while 5 had no therapy with antidiabetic agents.
Twenty-one normotensive, healthy volunteers (10 males, 11 females) ranging in age from 23 to 81 years served as control persons.
From each patient and from the healthy control persons 12-hours urine specimens were collected (8:00 p.m. to 8:00 a.m.). Additional serum samples were obtained after overnight fasting. Aliquots of serum and urine were combined with ΙΟμΙ proteinase inhibitor solution per ml sample (0.1 mol/1 phenyl-methyUsulphon yl-fluoride in dimethylsulphoxide; Sigma Chemicals, St. Louis, MO, USA) and stored at -20 °C for further use.
Quantities measured in general
Endogenous creatinine clearance was determined by measuring serum and urine creatinine with an automated creatinine analyzer (Model R2, Beckman Instruments GmbH, Munich, Germany). Glucose was analysed with a commercially available test kit (Boehringer, Mannheim, Germany) and total urinary protein according to Bradford (13) . Urinary albumin was determined by rocket-immuno-electrophoresis (14) .. Anti-human-albumin antibodies and purified human albumin were purchased from Behring Werke AG (Marburg, Germany Collagen IV in serum and urine was analysed by a sandwich-enzyme-linked-immunosorbent-assay. Specific antibodies were raised in rabbits against human placental collagen IV (Sigma chemicals, St. Louis, MO, USA) and purified by affinity chromatography on Protein-A-Sepharose (Pharmacia-LKB, Uppsala, Sweden). To measure collagen IV concentrations, high affinity flat-bottom microtitre plates (Greiner, N rtingen, Germany) were coated with anti-collagen IV antibodies, diluted 1 :200 in coating buffer (15 mmol/1 Na 2 CO 3 , 35 mmol/1 NaHCO 3 , 0.3 mol/1 NaN 3 , pH 9.6), at + 4 °C overnight. Remaining free binding sites on the plastic surface were blocked with 2 g/1 bovine serum albumin in phosphate buffered saline (0.15 mmol/1 NaCl, 8 mol/1 Na 2 HPO 4 , 3 mmol/1 KC1, 1.5 mmol/1 KH 2 PO 4 , 0.3 mol/1 NaN 3 , 0.5 ml/1 Tween 20, pH 7.4). Thereafter, urine and serum samples were incubated in parallel with the collagen IV standards (human placental collagen IV; Sigma Chemicals, St. Louis, MO, USA) in a serial dilution from 1 to 2500 μg/l in phosphate buffered saline. Bound antigens were detected with the same anti-collagen IV antibody used in the first step, but now coupled to alkaline phosphatase (dilution 1 : 1000 in phosphate buffered saline The inter-assay coefficient was 12% and the intra-assay coefficient was 10%. Cross reactions with other collagen types and structural proteins such as laminin and fibronectin could not be observed.
Total fibronectin was determined with a sandwich-enzyme-Iinkedimmunosorbent-assay (17) . Anti-human plasma fibronectin was purchased from Dako AS (Copenhagen, Denmark) and purified human plasma fibronectin from Sigma Chemicals (St. Louis, MO, USA). Conjugation of alkaline phosphatase to the antirfibronectin antibody was also performed as described by Avrameas (16) .
Immunoblotting of fibronectin
The urinary proteins were separated in a 5-16% sodium dodecylsulphate-polyacrylamide gradient gel prior to the blotting procedure. Slabgels were prepared on GelBond PAG films (125 X 260 mm; Pharmacia LKB, Uppsala, Sweden), in a gel casting chamber, 125 X 260 X 0.5 mm (Pharmacia LKB, Uppsala, Sweden). The running gel was prepared of equal volumes of dense acrylamide solution (160 g/1 acrylamide, 3 g/I bis-acrylamide; 170 g/I sucrose, 1 g/1 sodium dodecylsulphate, 0.4 ml/1 tetramethylene diamine, 0.4 g/1 ammonium persulphate in 0.4 mol/1 Tris HC1 buffer, pH 8.6), and light solution (50 g/1 acrylamide, 2 g/1 bis-acrylamide; 1 g/1 sodium dodecylsulphate, 0.4 ml/1 tetramethylene diamine, 0.4 g/1 ammonium persulphate in 0.4 rnol/1 Tris HC1 buffer, pH 8.6), mixed with a gradient former. The stacking gel was composed as follows: 50 g/1 acrylamide, 0.2 g/1 bis-acrylamide, 0.8 g/l sodium dodecylsulphate, 0.8 ml/1 tetramethylene diamine, 0.8 g/1 ammonium persulphate in 0.06 mol/1 Tris HC1 buffer, pH 6.8.
Samples were combined with equal volumes of sample buffer (10 ml/1 glycerol, 20 g/1 sodium dodecylsulphate, 10 ml/1 rnercaptoethanol in 75 mmol/I Tris HC1 buffer, pH 6.8). They were heated at 95 °C for 10 min, alkylated with 10 g/1 iodoacetic acid, and heated again for 20 min at 95 °C. Bromophenol blue was used as front marker. Molecular mass standard (biotinylated SDS-PAGE standard, low range and high range, Biorad, Richmond, CA, USA) and purified plasma fibronectin were run in parallel.
A buffer containing 25 mmol/1 Tris HC1, and 200 rnmol/J glycine, pH 8.6, was used for electrophoresis, which was performed in a Multiphor II Electrophoresis Unit (Pharmacia LKB, Uppsala, Sweden) at + 5 °C for 30 min at 20 mA and then for 2.5 h at 30 mA.
Proteins were transferred onto nitrocellulase (Transfer Membrane Immobilon P, pore size 0.45 μπι; Millipore Corporation, Bedford, MA, USA) after electrophoresis by semidry-blotting (Sartoblot-II-S, Sartorius, G ttingen, Germany) in a discontinuous buffer system (18) . The protein transfer was performed at 1.5 m A/cm 2 for 45 min. Thereafter, nitrocellulose was incubated in 20 g/1 casein in phosphate buffered saline (140 mmol/1 NaCl, 1.5 mmol/1 KH 2 PO 4 , 10 mmol/1 Na 2 HPO 4 , 2.5 mmol/1 KC1, 0.3 mol/1 NaN 3 , pH 8.2) for 1 hour at 37 °C. The immunologic reactions were performed with appropriate antibodies diluted in 2 g/1 casein, and 0.5 ml/1 Tween 20 in phosphate buffered saline. The following detection system was used for the detection of urinary fibronectin: anti-human-fibronectin-antibodies (diluted 1 :4000; incubation: 1 hour at 37 °C), biotinylated anti-rabbit-IgG-antibodies (diluted 1 :2000: incubation: 1 hour at 37 °C), streptavidin coupled to alkaline phosphatase (diluted 1 : 2000; incubation: 1 hour at 37 °C). All antibodies were purchased from Dako AS (Copenhagen, Denmark). Nitrocellulose was rinsed five times for 5 min with phosphate buffered saline between each incubation step. The bound antibodies were visualized by the enzymatic reaction of the coupled alkaline phosphatase as described by Blake et al. (19) .
Statistical analysis
For statistical analysis, the correlation coefficient was determined and the Mann-Wlrifney test for independent samples was used. The level of significance was defined as α = 0.05.
Results
Quantities measured in general
Currently, the determination of the urinary albumin excretion is the best method to identify patients with a high risk of diabetic nephropathy, since microalbuminuria (urinary albumin excretion > 20-70 μg/min) is predictive of the development of this diabetic complication. The aim of the present study was to evaluate whether the urinary excretion of extracellular matrix proteins gives additional information about the renal involvement in diabetes. The diabetic patients included in this study were therefore grouped according to their urinary albumin excretion. Diabetics with normal urinary albumin excretion below 30 μg/min, with microalbuminuria (urinary albumin excretion 30-200 μg/min), and with overt albuminuria (urinary albumin excretion above 200 μg/min) were differentiated. In table 2 the functional quantities such as creatinine clearance, total urinary protein excretion, and urinary albumin excretion determined for the patients and the control persons are given. With regard to these quantities no significant differences between type I and type II diabetics could be found within the three groups of diabetics. As intrinsic components of the renal extracellular matrix laminin, collagen IV, and fibronectin were determined in serum and in urine of the patients and the healthy controls.
Since none of the quantities tested were different in type I and type II diabetic patients, the results for the two groups are presented together.
Laminin
The serum concentration and the urinary excretion of laminin was determined. It can be seen that the serum concentrations ( fig. la) and the urinary excretion (fig. Ib) of this extracellular matrix protein did not change with the progression of renal involvement in diabetes as monitored by the urinary albumin excretion. Further, both quantities were also unaltered in comparison to the control group.
Collagen IV Serum concentration of collagen IV ( fig. 2a ) was diminished in all diabetic patients compared to the control persons (a < 0.01).
The urinary excretion of collagen IV is shown in figure  2b . No detectable amounts of collagen IV could be found in the urine of the control group, whereas 2% of the normoalbuminuric diabetics, 45% of the microalbuminuric, and 50% of the macroalbuminuric patients excreted detectable amounts of collagen IV. The controls and the patients with normal albumin excretion showed no significant difference in collagen IV excretion, while the patients with microalbuminuria and with overt albuminuria excreted significantly higher amounts of this protein (a < 0.001).
Serum concentrations and urinary excretion of collagen IV did not correlate to other quantities such as duration of diabetes, HbA lc , creatinine clearance, urinary excretion of protein and albumin.
Fibronectin
Serum fibronectin was elevated in all diabetic patients (a < 0.0001; fig. 3a ). The determination of urinary fibronectin showed an increased excretion in all diabetic patients compared to the control group (a < 0.001; fig.  3b ). Serum concentration and urinary excretion of fibron ectin did not correlate to the duration of diabetes, HbA IC , creatinine clearance, urinary excretion of protein and albumin, and urinary excretion of collagen IV.
To investigate whether the elevated urinary excretion of fibronectin is accompanied by alterations of the pattern of the breakdown products of fibronectin found in urine, additional qualitative studies in the urine by immunoblotting were performed. It was shown that fibronectin was excreted in a distinct, recurrent fragment pattern consisting of two main proteins bands with an apparent relative molecular mass of M T 75000, and 45000 ( fig. 4 ). The fragment pattern was similar in controls and in diabetic patients, independent of the stage of renal involvement in diabetes, and of the type of diabetes. This demonstrates the existence of a very early quantitative but no qualitative change in urinary fibronectin excreted in diabetic patients.
Discussion
Diabetes induces morphological alterations in the kidney, such as glomerular basement membrane thickening and expansion of the mesangial matrix, which occurs prior to albuminuria and changes of glomerular filtration rate (2, 20) . Methods based on the measurement of these functional quantities, routinely used in the diagnosis of diabetic nephropathy, lack the sensitivity required for early detection of the above mentioned structural changes, because the kidney has considerable functional reserves (21) . To date, basement membrane thickening and mesangial expansion can only be diagnosed by biopsy, which is not indicated to monitor the renal involvement in diabetes. Therefore, this study was designed to evaluate whether the urinary excretion of extracellular matrix components in diabetic patients might be able to reflect the alterations in renal morphology and the underlying biochemical processes.
Type I as well as type II diabetic patients were included in this study because both groups are affected by diabetic nephropathy (5, (22) (23) (24) . Since the two groups did not differ significantly with regard to the quantities measured in general, no distinction was made between them in the following discussion.
The extent of renal involvement in diabetes was specified by the urinary albumin excretion since microalbuminuria is currently the most sensitive marker and predictive for the development of diabetic nephropathy (2). Laminin, collagen IV, and fibronectin were determined since these proteins are principal components of the renal extracellular matrix. Laminin, measured as laminin PI-fragment, is predominantly localized at the endothelial site of the laminae rarae, where it is responsible for cell attachment and probably contributes, besides the proteoglycans, to the charge selectivity of the basement membrane (25, 26). Immunohistochemical studies by Falk et al. (6) showed an increase of laminin in the glomerular and tubular basement membrane, and in the mesangial matrix in early and moderate diabetic nephropathy, whereas the content of this protein was decreased in severe nephropathy. Shimomura et al. (27) and Karttunen et al. (28) found a decreased laminin concentration in the diabetic basement membrane by biochemical methods. No significant difference in serum laminin concentrations and in the urinary excretion of this protein was found between the diabetic patients and the control persons in this study. The slight increase of the lamiriin Pi-frag^· ment in the serum of diabetic patients, as described by Hoegemann et al. (29), could not be confirmed. The results of the present study indicate f that the laminin concentration in serum and in urine is independent of the stage of diabetic nephropathy, and that laminin excretion in urine is not able to reflect the changes this protein underlies in the diabetic kidney.
Collagen IV, which provides a resilient three-dimensional network forming the backbone of the glomerular basement membrane, is another important constituent of the renal extracellular matrix determined in this study (30-32). In the diabetic kidney, changes in the metabolism of collagen IV are principally responsible for the thickening of the glomerular basement membrane (6, 8, 33) . The metabolic disorders lead to an increased synthesis of this protein and further to a decreased degradation which results in an accumulation of collagen IV in the glomerular basement membrane (34-36). The determination of collagen IV in serum showed significantly decreased concentrations in the diabetic patients in cqmparison to controls. This is in contrast to findings of others, who found an increased serum concentration of collagen IV in diabetic patients (29, 37) or no alterations (12) . The decreased serum concentration of collagen IV found in the present study is interpreted as a consequence of the decreased degradation of this pro- tein in nearly all basement membranes. The urinary excretion of collagen was significantly increased in patients with microalbuminuria and with overt albuminuria. This is in agreement with findings of Torfjvit et al. (12) , who additionally found a decreased urinary excretion of collagen IV in advanced diabetic nephropathy. The results show that the determination of collagen in urine is able to reflect the alterations of this protein in the diabetic kidney. It is suggested that the destruction of the glomerular basement membrane in the course of the progressing glomerular sclerosis is responsible for the elevated urinary excretion of this protein. But since the collagen IV excretion raises in parallel to the albumin excretion, its determination in final urine yields no additional information to the quantities routinely used.
Fibronectin, as an intrinsic component of the renal extracellular matrix, was also determined. This protein is predominantly localized in the mesangial matrix (7, 26, 38 The urinary fibronectin excretion was elevated prior to the onset of microalbuminuria. This could coincide with the accumulation of this protein in the mesangial matrix in early and moderate diabetic nephropathy (6, 7) and, thus, reflect the impaired fibronectin metabolism in the diabetic kidney. I '
Since the urinary excretion of fibronectin seems to be valuable in assessing the early involvement of the kidney in diabetes, it was studied not only quantitatively but also qualitatively by immunoblotting. The protein was excreted in a distinct fragment pattern of two main bands with an apparent relative molecular mass of A/ r 75 000, and 45 000 in the urine of control persons and of diabetic patients at different stages of nephropathy. The unaltered and recurring fragment pattern indicates that these fragments are products of a defined turnover of fibronectin in the kidney. Its quantitatively elevated excretion in parallel to its unchanged qualitative excretion suggests an inbalanced turnover in diabetes.
Metabolic and micropuncture experiments in rats demonstrated that the urinary fibronectin fragments originate from the glomeruli and that the fragment pattern is not altered during tubular passage. Serum fibronectin is found in final urine only in cases of severe glomerular damage, when high molecular mass plasma proteins are allowed to permeate the glomerular filter (45, 46).
From the results of the present study the following cascade of events is hypothesized. The accumulation of extracellular matrix proteins is probably due to the high glucose concentration in the tissue, which is supposed to stimulate the protein synthesis and to diminish the protein degradation (48) (49) (50) . The non-enzymatic glycation of the proteins, and the formation of oxygen radicals are the suggested mechanisms through which glucose causes these biochemical alterations (51-54). The expanding mesangium, which compresses the capillary vasculature and ultimately leads to glomerular closure, is thought to be the primary cause for the development of diabetic nephropathy rather than the loss of the charge and size selectivity of the glomerular filtration barrier (4, 55) .
Conclusion
We show in this study that
(1) the changes laminin undergoes in diabetes are not reflected by its urinary excretion, (2) collagen IV excretion is elevated in parallel to the occurrence of microalbuminuria and probably reflects the decline of the glomerular basement membrane, (3) urinary fibronectin is elevated in diabetic patients prior to functional restrictions and probably reflects the mesangial expansion due to the accumulation of extracellular matrix proteins probably caused by increased glucose concentration in the tissue.
With regard to these findings, urinary fibronectin excretion may serve as an early marker for the renal involvement in diabetes, but further studies are necessary to substantiate this assumption.
